Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Richard W Tothill

Showing results (31-40 of 69) with videos related to

Pageof 7
Sort By:
BMC Medical Genomics|August 2, 2015
Loss of heterozygosity: what is it good for?Georgina L Ryland, Maria A Doyle, David Goode, et al.
Nature Communications|November 14, 2024
Unravelling mutational signatures with plasma circulating tumour DNASebastian Hollizeck, Ning Wang, Stephen Q Wong, et al.
The Journal of Clinical Endocrinology and Metabolism|January 23, 2016
Pheo-Type: A Diagnostic Gene-expression Assay for the Classification of Pheochromocytoma and ParagangliomaAidan Flynn, Trisha Dwight, Jessica Harris, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 1, 2018
Circulating Cell-Free miR-375 as Surrogate Marker of Tumor Burden in Merkel Cell CarcinomaKaiji Fan, Cathrin Ritter, Paul Nghiem, et al.
Genome Research|September 6, 2011
Genome-wide analysis distinguishes hyperglycemia regulated epigenetic signatures of primary vascular cellsLuciano Pirola, Aneta Balcerczyk, Richard W Tothill, et al.
The Journal of Pathology|December 30, 2014
The genomic landscape of phaeochromocytomaAidan Flynn, Diana Benn, Roderick Clifton-Bligh, et al.
Journal for Immunotherapy of Cancer|October 16, 2020
Clinical, FDG-PET and molecular markers of immune checkpoint inhibitor response in patients with metastatic Merkel cell carcinomaAlison M Weppler, Andrew Pattison, Prachi Bhave, et al.
Plos One|October 3, 2013
Next-generation sequence analysis of cancer xenograft modelsFernando J Rossello, Richard W Tothill, Kara Britt, et al.
Cell Reports|December 4, 2014
Cohesin Rad21 mediates loss of heterozygosity and is upregulated via Wnt promoting transcriptional dysregulation in gastrointestinal tumorsHuiling Xu, Yuqian Yan, Siddhartha Deb, et al.
JCO Precision Oncology|January 7, 2022
Novel RET Fusion <i>RET-SEPTIN9</i> Predicts Response to Selective RET Inhibition With Selpercatinib in Malignant PheochromocytomaAngela Mweempwa, Huiling Xu, Joseph H A Vissers, et al.
Pageof 7

Showing results (31-40 of 69) with videos related to

Sort By:
Pageof 7
BMC Medical Genomics|August 2, 2015
Loss of heterozygosity: what is it good for?Georgina L Ryland, Maria A Doyle, David Goode, et al.
Nature Communications|November 14, 2024
Unravelling mutational signatures with plasma circulating tumour DNASebastian Hollizeck, Ning Wang, Stephen Q Wong, et al.
The Journal of Clinical Endocrinology and Metabolism|January 23, 2016
Pheo-Type: A Diagnostic Gene-expression Assay for the Classification of Pheochromocytoma and ParagangliomaAidan Flynn, Trisha Dwight, Jessica Harris, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 1, 2018
Circulating Cell-Free miR-375 as Surrogate Marker of Tumor Burden in Merkel Cell CarcinomaKaiji Fan, Cathrin Ritter, Paul Nghiem, et al.
Genome Research|September 6, 2011
Genome-wide analysis distinguishes hyperglycemia regulated epigenetic signatures of primary vascular cellsLuciano Pirola, Aneta Balcerczyk, Richard W Tothill, et al.
The Journal of Pathology|December 30, 2014
The genomic landscape of phaeochromocytomaAidan Flynn, Diana Benn, Roderick Clifton-Bligh, et al.
Journal for Immunotherapy of Cancer|October 16, 2020
Clinical, FDG-PET and molecular markers of immune checkpoint inhibitor response in patients with metastatic Merkel cell carcinomaAlison M Weppler, Andrew Pattison, Prachi Bhave, et al.
Plos One|October 3, 2013
Next-generation sequence analysis of cancer xenograft modelsFernando J Rossello, Richard W Tothill, Kara Britt, et al.
Cell Reports|December 4, 2014
Cohesin Rad21 mediates loss of heterozygosity and is upregulated via Wnt promoting transcriptional dysregulation in gastrointestinal tumorsHuiling Xu, Yuqian Yan, Siddhartha Deb, et al.
JCO Precision Oncology|January 7, 2022
Novel RET Fusion <i>RET-SEPTIN9</i> Predicts Response to Selective RET Inhibition With Selpercatinib in Malignant PheochromocytomaAngela Mweempwa, Huiling Xu, Joseph H A Vissers, et al.
Pageof 7